Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
about
The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomasPlasma levels of MMP-7 and TIMP-1 in laboratory diagnostics and differentiation of selected histological types of epithelial ovarian cancers.Use of CA125 and HE4 serum markers to predict ovarian cancer in elevated-risk womenRelationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification.Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patientsdbEMT: an epithelial-mesenchymal transition associated gene resource.Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancerSerum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer.The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors.Gene expression analyses support fallopian tube epithelium as the cell of origin of epithelial ovarian cancer.The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review.Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.The role of biomarkers in the management of epithelial ovarian cancer.MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo.Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway.
P2860
Q26992102-91C6160A-E1D3-420E-A7A7-8EA436D65A4EQ32173966-837EFB05-CF09-4287-84E9-D9A6BC9CA1ACQ33848119-A5B97E6D-411E-47D5-B592-2CCAB2836ED7Q35248417-DA689442-2922-4BDA-9B99-C6F7BE4C4966Q35539470-CD1E6E1B-0115-409B-B415-EF29035EC915Q35589339-43D1036D-C57E-45E3-8321-D1F5A499EB7BQ35769090-6468DD2E-BFED-4624-824E-F2E3B07EA064Q36385490-312C551C-DEFF-43F9-A9F9-C8F560CB013CQ36742117-D574FF97-79A7-4FD7-BDDE-5E9E7AB3C7EBQ36808757-02425140-8DEF-4798-A115-57AC430AE83FQ36954678-A150E179-FE5A-4A6B-A4E2-04E5BA06AC46Q36996525-D4707120-E52A-41C7-A574-6BBDEA0EC53DQ37091852-D71D9AB0-2AC9-4618-9A34-1C9BA9463FF6Q38653169-559A9276-9022-4559-A675-09B9F2BDAD52Q38730370-7BC7E31A-3B7D-403E-8DD6-0686F5444785Q39281140-B9CB48B0-B0C3-4FD2-AC08-EA3613DAF7F9Q40859822-5D033420-3C7C-40F0-A11D-2488E43C0B6DQ45849410-71EE0C55-2A7E-45F2-9B6B-2985E947BD59Q47097061-ED57DA9D-7B9E-4ED9-A41F-071EC6BBEE20Q47797102-B1BE289E-BE2F-4F97-B5B6-E3DF6C91BB99Q49658859-C220A955-D181-4B9D-9530-8E5B14B2A651Q51415152-BDA61A60-9ED9-4191-A5F2-3B68989A3D38
P2860
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Evaluation of ovarian cancer r ...... o the established marker CA125
@ast
Evaluation of ovarian cancer r ...... o the established marker CA125
@en
type
label
Evaluation of ovarian cancer r ...... o the established marker CA125
@ast
Evaluation of ovarian cancer r ...... o the established marker CA125
@en
prefLabel
Evaluation of ovarian cancer r ...... o the established marker CA125
@ast
Evaluation of ovarian cancer r ...... o the established marker CA125
@en
P2093
P2860
P1433
P1476
Evaluation of ovarian cancer r ...... o the established marker CA125
@en
P2093
Charles Drescher
Ingegerd Hellström
Jason Thorpe
Karl Erik Hellström
Michèl Schummer
Nicole Urban
Robin Forrest
Shirley Gough
P2860
P356
10.1016/J.YGYNO.2011.11.050
P407
P577
2011-12-07T00:00:00Z